Oxytocin

Oxytocin is a nine-amino-acid peptide hormone and neuropeptide naturally produced in the hypothalamus and released by the posterior pituitary. Known as the "love hormone" or "bonding hormone," it plays fundamental roles in social bonding, trust, empathy, sexual reproduction, childbirth, and lactation. Synthetic oxytocin (Pitocin/Syntocinon) is FDA-approved for labor induction and postpartum hemorrhage control, while intranasal formulations are being researched for autism spectrum disorders, anxiety, depression, PTSD, chronic pain, and sexual dysfunction.

• Social Bonding and Trust
• Autism Spectrum Disorders
• Social Anxiety

FDA-approved for labor induction and postpartum hemorrhage control, precise dosing via IV infusion, immediate onset, well-established safety profile in obstetric settings

Binds to oxytocin receptors (OXTR) on uterine smooth muscle cells, triggering calcium influx and myometrial contractions. Also stimulates prostaglandin release to enhance uterine sensitivity.

Peak plasma concentration: 30 min. Elimination half-life: 20 min. Largely cleared by: ~1.7 hrs.

Research protocols from published literature — not dosing recommendations.

• Vasopressin (AVP) — Monitor Combination: Structurally similar peptides (differ by only 2 amino acids) with overlapping receptor affinity. Both act on oxytocin and vasopressin receptors with potential for additive effects.
• Selank — Synergistic: Complementary anxiolytic effects through different mechanisms. Selank modulates GABA while oxytocin acts on central oxytocin receptors for stress reduction.
• Semax — Compatible: No known interactions. Different mechanisms - Semax for cognitive enhancement, oxytocin for social/emotional support.
• PT-141 (Bremelanotide) — Synergistic: Complementary effects on sexual function. PT-141 acts on melanocortin receptors while oxytocin enhances bonding, arousal, and orgasm intensity.
• Kisspeptin — Synergistic: Both involved in reproductive function through different pathways. Kisspeptin stimulates GnRH while oxytocin enhances arousal and bonding.
• BPC-157 — Compatible: No known direct interactions. Different mechanisms - BPC-157 for tissue repair, oxytocin for social/reproductive functions.
• SSRI Antidepressants — Monitor Combination: SSRIs may affect endogenous oxytocin levels. Combined use may have additive effects on mood but should be monitored by healthcare provider.
• Benzodiazepines — Use Caution: Both have anxiolytic effects through different mechanisms. Combined use may cause enhanced sedation or additive effects on blood pressure.
• Prostaglandins — Synergistic: Prostaglandins enhance oxytocin sensitivity in uterine tissue. Often used together clinically for labor induction.
• Alcohol — Avoid Combination: Alcohol suppresses oxytocin release and may reduce therapeutic effects. Both can affect blood pressure and judgment.

Supplies:

• Oxytocin injection USP (10 units/mL)
• Compatible IV solution (0.9% NaCl or Lactated Ringer's)
• IV infusion pump (required for labor)
• Continuous fetal monitoring equipment
• Blood pressure monitoring

1. 1This is a hospital/clinical procedure performed by healthcare professionals
2. 2Dilute oxytocin in compatible IV solution per facility protocol
3. 3Typical dilution: 10 units in 1000mL = 10 mU/mL
4. 4Use infusion pump for precise rate control
5. 5Monitor uterine contractions and fetal heart rate continuously
6. 6Adjust rate based on clinical response and safety parameters
7. 7Have emergency medications available (terbutaline for tocolysis)

Used exclusively in clinical/hospital settings. Immediate onset of uterine contractions (IV). Requires continuous monitoring of contractions and fetal heart rate. Effects diminish rapidly after discontinuation (short half-life ~3-5 min). May cause transient blood pressure changes. Common side effects: nausea, vomiting, headache.

Must be administered only by qualified healthcare professionals. Requires continuous electronic fetal monitoring during labor. Uterine hyperstimulation is the primary concern - can cause fetal distress. Contraindicated in certain obstetric conditions (see prescribing information). Water intoxication risk with high doses or prolonged infusion. Have tocolytic agents available for uterine hyperstimulation.

Must be administered only by qualified healthcare professionals. Requires continuous electronic fetal monitoring during labor. Uterine hyperstimulation is the primary concern - can cause fetal distress. Contraindicated in certain obstetric conditions (see prescribing information). Water intoxication risk with high doses or prolonged infusion. Have tocolytic agents available for uterine hyperstimulation.

Oxytocin should be stored at Refrigerate 2-8°C, protect from light.